Fernando et al.9 have shown that Sorafenib sensitizes HCC cells to the apoptotic activity of TGF-β through the intrinsic pathway and tumor necrosis factor-α (TNF-α)-dependent extrinsic pathway. Here, TGFB1 is linked to hepatocellular carcinoma.